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A reactivation of varicella zoster virus (VZV) may result in severe dermatomal,  ophthalmic,  splanch-
nic,  cerebral,  and motor complications.  Because VZV 
is a neurotropic virus in the Herpesviridae family,  the 
most common and troubling symptom of VZV reacti-
vation is prolonged neuralgia.  Serious neural and cere-
bral complications such as cranial polyneuritis and 
meningitis are rare [1].  There are no established meth-
ods for treating cranial polyneuritis and meningitis 
caused by VZV,  and there are few published reports on 
the treatment and outcomes of patients with cranial 
polyneuritis and meningitis due to VZV reactivation 
[1-5].  Early diagnosis and treatment with acyclovir and 
corticosteroids is important,  but only ～30% of patients 
experience a full recovery [4].
A multicenter prospective cohort study revealed that 
restoring the physiological vitamin C plasma concen-
tration by administering intravenous vitamin C may 
promote recovery from VZV-associated shingles,  and 
that doing so may relieve VZV-associated pain [6 , 7].  
Vitamin C might thus have a beneficial effect on recov-
ery from VZV-associated neuritis.  We report the case of 
our patient with cranial polyneuritis and meningitis due 
to VZV; the patient achieved a full recovery in 
response to the concomitant use of intravenous vitamin 
C,  acyclovir,  and corticosteroids.
Case Report
A 65-year-old Japanese woman visited an otologist 
because of vesicular eruptions and pustules in her right 
auricle and external auditory canal (Fig. 1A).  She was a 
hepatitis B virus (HBV) carrier but did not have a his-
tory of viral hepatitis.  She had no chronic medical con-
ditions or medical disease history of note.  She was 
diagnosed as having VZV reactivation and was treated 
with oral valaciclovir hydrochloride (1,500 mg daily).  
Her physical condition deteriorated,  and she visited the 
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A 65-year-old Japanese woman developed vesicular eruptions on her right ear due to varicella zoster virus 
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lone and vitamin C were administered on Day 4 post-admission.  Her symptoms steadily improved,  and by Day 
45 she had fully recovered.  Cranial polyneuritis is a rare complication of VZV reactivation,  and there is no 
established method of treatment.  This is the first report of full recovery from cranial polyneuritis using intrave-
nous vitamin C as ancillary treatment.
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emergency department of our hospital with severe 
headache and a 2-day history of dysphagia.
On presentation,  the patient was alert and,  except 
for an axillary temperature of 37.6°C,  her vital signs 
were normal.  On neurological examination,  she was 
found to have a hoarse voice,  right-sided peripheral 
facial asymmetry,  hypoesthesia on the right side of her 
face (Fig. 1B),  hearing loss in her right ear,  and an 
absent gag reflex.  Her uvular was deviated to the left 
(Fig. 1C) but her tongue movement was normal.  Her 
eye movement and light reflection was normal.  She did 
not have signs of neck or limb stiffness,  or paralysis of 
her extremities.  She was clinically diagnosed as having 
neuritis of her right cranial nerves (V,  VII,  VIII,  IX,  
and X) and was admitted to our hospital.
Her cerebrospinal fluid contained 46 lymphocytes/μL,  
with normal pressure and total protein levels.  VZV-
DNA was detected by the real-time polymerase chain 
reaction (PCR) method [8].  Her blood tests revealed no 
obvious signs of infection.  She had a normal neutrophil 
count,  and no atypical lymphocytes were detected.  She 
was seropositive for VZV immunoglobulins G (IgG) 
and M (IgM) (Table 1).  Her results of IgG anti-GM1,  
and IgG anti-GQ1b were negative,  ruling out a diagno-
sis of Guillain-Barré syndrome or Fisher syndrome.
T2-weighted magnetic resonance imaging revealed 
high signal intensity in the basal neural canal and the 
right inner auditory canal (Fig. 2).  No abnormalities 
associated with sarcoidosis,  malignant lymphoma,  or 
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???? ?　 The patientʼs physical signs.  A,  Vesicular eruptions and 
pustules in the right ear auricle; B,  Facial nerve palsy on the right 
side of the face; C,  Right vocal cord paralysis and deviated uvula 
saliva retention by laryngoscopy.
????? ?　 The patientʼs laboratory test on admission
Hematology
White blood 
cells
4,800 cells/μL Red blood cells 480×104/μL
Neutrophils 52.5% Hemoglobin 14.3 g/dL
Eosinophils 1.0% Platelet count 18.4×104/μL
Monocytes 6.5% Prothrombin time 12.1 sec
Lymphocytes 38.0% APTT 29.3 sec
Atypical 
lymphocytes
0% D-dimer 0.5 μg/mL
Blood biochemistry
Total protein 7.7 g/dL BUN 21.0 mg/dL
Albumin 4.6 g/dL Creatinine 0.55 mg/dL
Total bilirubin 1.0 mg/dL Sodium 138 mEq/L
AST 27 IU/L Potassium 4.1 mEq/L
ALT 19 IU/L CRP 0.06 mg/dL
ALP 261 IU/L Glucose 76 mg/dL
Serum viral,  autoimmune,  tumor markers
HBs antigen 566 IU/mL Anti-GM1 IgG negative
HBV-DNA 1.8 Log IU/mL Anti-GQ1b IgG negative
VZV IgM 1.26 COI
VZV IgG 128 COI ACE 14 IU/L
VZV-DNA negative sIL-2R 233.9 U/mL
HSV-DNA negative
CMV-DNA negative
Cerebrospinal fluid findings
Neutrophils 0 μ/mL VZV-DNA positive
Monocytes 46 μ/mL HSV-DNA negative
Protein 36 mg/dL CMV-DNA negative
???? ?　 MRI of the patientʼs head.  High signal intensity at the 
right inner auditory canal and the basal neural canal on T2-weighted 
imaging.
other malignancies were detected on the CT scan of her 
whole body,  endoscopic examination of her gastroin-
testinal tract,  or laboratory findings.  She was diag-
nosed with cranial polyneuritis and meningitis due to 
VZV reactivation.
We started treatment with intravenous acyclovir at 
10 mg/kg of body weight every 8 h.  Her facial paralysis 
and headache became more severe after admission.  By 
Day 3 she had developed an obvious gait disorder with 
pain in her legs and buttocks,  associated with meningi-
tis.  On Day 4,  we concomitantly administered 1g of 
methylprednisolone and 2 g of vitamin C intravenously,  
with 0.5 mg of oral entecavir to prevent HBV reactiva-
tion.  After 3 days of the intravenous methylpredniso-
lone,  the patient was started on oral prednisolone,  
which was gradually tapered from 40 mg/day to 5 mg/day 
over a period of 7 weeks.  Her dysphagia and hoarse 
voice had resolved by Day 13 of her hospitalization.
The patient’s neurological disorders resolved,  and 
she was able to eat jelly on Day 15 and a normal meal on 
Day 26.  Her clinical course is shown in Fig. 3.  She was 
discharged on Day 45,  having fully recovered from her 
polyneuritis.  Since her discharge from hospital approx.  
She has not experienced a recurrence of neuritis.
Discussion
Our patient had cranial polyneuritis and meningitis 
due to VZV reactivation.  A VZV reactivation can be 
triggered by emotional stress,  physical trauma,  smok-
ing,  recent viral infection,  and decreased cell-mediated 
immunity,  as a feature of advancing age or an immuno-
compromised state [9].  The neurological disorders that 
have been associated with VZV reactivation include 
neuralgia,  meningitis,  meningoencephalitis,  cerebelli-
tis,  vasculopathy,  myelopathy,  Ramsay-Hunt syn-
drome,  and cranial polyneuritis [9]; there are few 
published reports of cranial polyneuritis as a rare com-
plication.
There are no established methods for treating cranial 
polyneuritis and meningitis caused by VZV.  It has been 
reported that the neurological outcome is better if acy-
clovir and corticosteroids are administered soon after 
the onset [10],  but that only approx.  30% of patients 
experience a full recovery [4].  We administered high 
doses of corticosteroids and vitamin C intravenously on 
Day 4 of the patient’s hospitalization,  and by Day 45 
her paralysis had fully resolved.  This is the first report 
of cranial polyneuritis and meningitis due to VZV reac-
tivation in which the patient fully recovered from the 
neurological symptoms.  This case suggests that use of 
vitamin C in addition to acyclovir and corticosteroids 
may result in a better outcome.
Vitamin C is a water-soluble micronutrient that acts 
as a potent antioxidant,  cofactor of enzymes,  and neu-
romodulator [6 , 7].  Vitamin C acts as an antioxidant by 
scavenging reactive oxygen species to protect cells and 
tissues from oxidative damage.  The cofactor of enzymes 
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Weeks
Admission
Acyclovir
10mg/kg
mPSL 1g
0 1 2 3 4 5 6 7
Prednisolone
Vitamin C 2g
Shingles
40mg 30mg 20mg 15mg 10mg 5mg
hoarse voice
Hearing loss
Right fascial palsy
Dysphagia
Headache
Fever >37℃
Discharge
???? ?　 The clinical course of the patientʼs varicella zoster virus reactivation.  mPSL: methyl-prednisolone.
in Vitamin C is used for dopamine β-hydroxylase,  
which converts dopamine into norepinephrine.  The 
highest vitamin C levels are found in cells of the 
immune system and nerve cells,  reflecting the pivotal 
role of vitamin C in the function of these tissues.  
Vitamin C also plays a critical role in cellular immunity.
In cases of the reactivation of a VZV infection,  neu-
ronal tissues are vulnerable to oxidative stress,  and the 
utilization of vitamin C is increased due to the increased 
oxidation caused by VZV reactivation [6 , 7].  We did a 
PubMed search on the treatment of cranial polyneuritis 
and meningitis,  and the search did not identify any 
studies evaluating the effectiveness of vitamin C as 
ancillary treatment for cranial polyneuritis or meningitis.
The dose and duration of intravenous vitamin C 
treatment administered to prevent herpes zoster-asso-
ciated pain has varied from 2 to 15 g daily for 5-14 days 
[11].  It is recommended that the daily dose of intrave-
nous vitamin C should not exceed 10 g because high 
doses cause increased oxalate excretion and metabolic 
alkalosis [12].  We decided to administer the maximum 
recommended dose of intravenous vitamin C for the 
maximum recommended duration because our patient 
was depleted of vitamin C due to stress.  The dose and 
duration were also the maximum amounts that could be 
claimed from insurance coverage.
 The full recovery of our patient with cranial poly-
neuritis and meningitis due to VZV reactivation suggests 
that intravenous vitamin C might be an effective ancil-
lary treatment for cranial polyneuritis and meningitis.  
A prospective cohort study is needed to evaluate the 
effectiveness intravenous vitamin C as ancillary treat-
ment for cranial polyneuritis due to VZV reactivation.
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